Sex: F
Vaccine: COVID19, DTAPIPV, FLUC3, HEP, HEPA
Symptoms: Gait inability, Illness, Pyrexia
Clinical narrative: Could not walk for 3 days; Was very sick; Fever; This spontaneous case was received on 08-Mar-2024 from other healthcare professional via Company (reference number: SEQW24-00863) and concerned a female patient of an unreported age.  The patient had no concurrent conditions. The patient's concomitant medications were not reported. It was unknown if the patient ever been diagnosed with/tested for COVID-19. The patient had no allergies. The patient did not have any acute illnesses at the time of vaccination and up to one month before.   On 24-Oct-2023, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4V; dose, route of administration, anatomical location and indication: not reported). The batch number was not reported.  On the same date, the patient was vaccinated with a Covid-19 vaccine (reported as 'mRNA-1273.815 (SPIKEVAX 2023-2024)', active ingredients not specified; dose: 0.5 ml, route of administration: intramuscular, anatomical location: not reported), for Covid-19 prophylaxis. The reported batch number was 031322, Quadracel vaccine (diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid; dose, route of administration, anatomical location and indication: not reported), Recombivax vaccine (hepatitis b vaccine rHBsAg (yeast); dose, route of administration, anatomical location and indication: not reported), and Vaqta vaccine (hepatitis a vaccine inact; dose, route of administration, anatomical location and indication: not reported). The batch numbers were not reported.  On an unspecified day in Oct-2023, an unspecified amount of time after receiving Flucelvax Quadrivalent , Covid-19 vaccine, Quadracel, Recombivax and Vaqta, the patient was very sick, could not walk for three days and had fever for three days. Events did not even cause the patient to seek medical care. The patient did not have any other potential causes. The patient did not experience a similar event in the past. Treatment medications use information was not provided by reporter.   On an unspecified day in Oct-2023, the patient was doing better.   On an unspecified day in Oct-2023, the patient recovered from the events.   The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A female patient of an unreported age was vaccinated with Flucelvax Quadrivalent and non-company, co-suspects COVID-19 vaccine, Quadracel, Recombivax and Vaqta. Within seven days following vaccination, the patient experienced gait inability, illness and pyrexia. Although confounded by administration of co-suspect vaccines, causality is assessed as possible for all reported events, due to chronological plausibility.; Sender's Comments: female patient of an unreported age was vaccinated with Flucelvax Quadrivalent and non-company, co-suspects COVID-19 vaccine, Quadracel, Recombivax and Vaqta. Within seven days following vaccination, the patient experienced gait inability, illness and pyrexia. Although confounded by administration of co-suspect vaccines, causality is assessed as possible for all reported events, due to chronological plausibility.